Adma Biologics | ADMA - Cost Of Sales

Stock Price
16.43
Daily Change
0.49 3.07%
Monthly
-12.70%
Yearly
-1.68%
Q1 Forecast
16.77

Adma Biologics reported $58.64M in Cost of Sales for its fiscal quarter ending in September of 2025.





Cost Of Sales Change Date
Adma Biologics USD 58.64M 3.88M Sep/2025
Alnylam Pharmaceuticals USD 200.15M 57.2M Sep/2025
Dynavax Technologies USD 14.4M 368K Sep/2025
Takeda JPY 401.15B 184.07B Dec/2025